scholarly journals Effects of the N-terminal Domains of Myosin Binding Protein-C in anin VitroMotility Assay

2006 ◽  
Vol 281 (47) ◽  
pp. 35846-35854 ◽  
Author(s):  
Maria V. Razumova ◽  
Justin F. Shaffer ◽  
An-Yue Tu ◽  
Galina V. Flint ◽  
Michael Regnier ◽  
...  
2019 ◽  
Vol 116 (3) ◽  
pp. 266a
Author(s):  
Rhye-Samuel Kanassatega ◽  
Thomas A. Bunch ◽  
Victoria C. Lepak ◽  
Brett A. Colson

2011 ◽  
Vol 412 (3) ◽  
pp. 379-386 ◽  
Author(s):  
Albina Orlova ◽  
Vitold E. Galkin ◽  
Cy M.J. Jeffries ◽  
Edward H. Egelman ◽  
Jill Trewhella

Structure ◽  
2018 ◽  
Vol 26 (12) ◽  
pp. 1604-1611.e4 ◽  
Author(s):  
Cristina Risi ◽  
Betty Belknap ◽  
Eva Forgacs-Lonart ◽  
Samantha P. Harris ◽  
Gunnar F. Schröder ◽  
...  

2006 ◽  
Vol 98 (10) ◽  
pp. 1290-1298 ◽  
Author(s):  
Todd J. Herron ◽  
Elena Rostkova ◽  
Gudrun Kunst ◽  
Rajiv Chaturvedi ◽  
Mathias Gautel ◽  
...  

2021 ◽  
Vol 153 (3) ◽  
Author(s):  
Sheema Rahmanseresht ◽  
Kyoung H. Lee ◽  
Thomas S. O’Leary ◽  
James W. McNamara ◽  
Sakthivel Sadayappan ◽  
...  

Myosin and actin filaments are highly organized within muscle sarcomeres. Myosin-binding protein C (MyBP-C) is a flexible, rod-like protein located within the C-zone of the sarcomere. The C-terminal domain of MyBP-C is tethered to the myosin filament backbone, and the N-terminal domains are postulated to interact with actin and/or the myosin head to modulate filament sliding. To define where the N-terminal domains of MyBP-C are localized in the sarcomere of active and relaxed mouse myocardium, the relative positions of the N terminus of MyBP-C and actin were imaged in fixed muscle samples using super-resolution fluorescence microscopy. The resolution of the imaging was enhanced by particle averaging. The images demonstrate that the position of the N terminus of MyBP-C is biased toward the actin filaments in both active and relaxed muscle preparations. Comparison of the experimental images with images generated in silico, accounting for known binding partner interactions, suggests that the N-terminal domains of MyBP-C may bind to actin and possibly the myosin head but only when the myosin head is in the proximity of an actin filament. These physiologically relevant images help define the molecular mechanism by which the N-terminal domains of MyBP-C may search for, and capture, molecular binding partners to tune cardiac contractility.


Author(s):  
Bashir Alaour ◽  
Torbjørn Omland ◽  
Janniche Torsvik ◽  
Thomas E. Kaier ◽  
Marit S. Sylte ◽  
...  

Abstract Objectives Cardiac myosin-binding protein C (cMyC) is a novel biomarker of myocardial injury, with a promising role in the triage and risk stratification of patients presenting with acute cardiac disease. In this study, we assess the weekly biological variation of cMyC, to examine its potential in monitoring chronic myocardial injury, and to suggest analytical quality specification for routine use of the test in clinical practice. Methods Thirty healthy volunteers were included. Non-fasting samples were obtained once a week for ten consecutive weeks. Samples were tested in duplicate on the Erenna® platform by EMD Millipore Corporation. Outlying measurements and subjects were identified and excluded systematically, and homogeneity of analytical and within-subject variances was achieved before calculating the biological variability (CVI and CVG), reference change values (RCV) and index of individuality (II). Results Mean age was 38 (range, 21–64) years, and 16 participants were women (53%). The biological variation, RCV and II with 95% confidence interval (CI) were: CVA (%) 19.5 (17.8–21.6), CVI (%) 17.8 (14.8–21.0), CVG (%) 66.9 (50.4–109.9), RCV (%) 106.7 (96.6–120.1)/−51.6 (−54.6 to −49.1) and II 0.42 (0.29–0.56). There was a trend for women to have lower CVG. The calculated RCVs were comparable between genders. Conclusions cMyC exhibits acceptable RCV and low II suggesting that it could be suitable for disease monitoring, risk stratification and prognostication if measured serially. Analytical quality specifications based on biological variation are similar to those for cardiac troponin and should be achievable at clinically relevant concentrations.


Sign in / Sign up

Export Citation Format

Share Document